Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (381-390 of 385) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 385 results.
Nature Cancer|December 29, 2022
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trialClaudia M Denkinger, Maike Janssen, Ulrike Schäkel, et al.
Leukemia|October 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patientsMarius Bill, Jan-Niklas Eckardt, Konstanze Döhner, et al.
Blood Cancer Discovery|March 31, 2025
Enhancer hijacking discovery in acute myeloid leukemia by pyjacker identifies MNX1 activation via deletion 7qEtienne Sollier, Anna Riedel, Umut H Toprak, et al.
Leukemia|January 12, 2023
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONYLarry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, et al.
Leukemia|December 24, 2022
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONYLarry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, et al.
Pageof 39

Showing results (381-390 of 385) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 385 results.
Nature Cancer|December 29, 2022
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trialClaudia M Denkinger, Maike Janssen, Ulrike Schäkel, et al.
Leukemia|October 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patientsMarius Bill, Jan-Niklas Eckardt, Konstanze Döhner, et al.
Blood Cancer Discovery|March 31, 2025
Enhancer hijacking discovery in acute myeloid leukemia by pyjacker identifies MNX1 activation via deletion 7qEtienne Sollier, Anna Riedel, Umut H Toprak, et al.
Leukemia|January 12, 2023
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONYLarry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, et al.
Leukemia|December 24, 2022
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONYLarry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, et al.
Pageof 39